Mark Wegter

Mark Wegter

Chief Executive Officer at
LSP Advisory BV
56 year
Health Technology
Finance
Consumer Services

Profile

Mark A. Wegter currently serves as Director-Supervisory Board at PamGene International BV and PamGene BV since 2000.
Since 1998, Mr. Wegter is Managing Partner at LSP Advisory BV.
Since 2022, Mr. Wegter is Partner at EQT Life Sciences Group BV.
Former positions include Director-Executive Board at 4-Antibody AG from 2010 to 2011, Director at VitrOmics Healthcare Holding BV, Director at European Biotech Acquisition Corp.
from 2021 to 2023, Member-Management Board at Kiadis Pharma BV from 2009 to 2012, and Member-Supervisory Board at Kiadis Pharma NV from 2001 to 2015.
Education includes a graduate degree from Erasmus University Rotterdam conferred in 1995.

Mark Wegter active positions

CompaniesPositionStart
Private Equity Investor 01/01/1998
Director/Board Member 01/12/2000
Director/Board Member 14/10/2009
Chief Executive Officer 01/01/1998

Former positions of Mark Wegter

CompaniesPositionEnd
EURO BIOT Director/Board Member 28/02/2023
Director/Board Member 01/01/2015
Corporate Officer/Principal 01/01/2011
KIADIS PHARMA N.V. Chairman -
Chairman -
See the detail of Mark Wegter's experience

Training of Mark Wegter

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

72

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Finance

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Finance

Health Technology

Finance